Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| arabinofuranosyl derivatives | 771 | 73532-83-9 |
None
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 20 % |
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| FDA MoA | N0000000233 | Nucleic Acid Synthesis Inhibitors |
| MeSH PA | D000970 | Antineoplastic Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000963 | Antimetabolites |
| MeSH PA | D000964 | Antimetabolites, Antineoplastic |
| MeSH PA | D000998 | Antiviral Agents |
| MeSH PA | D007155 | Immunologic Factors |
| MeSH PA | D007166 | Immunosuppressive Agents |
| FDA EPC | N0000175595 | Nucleoside Metabolic Inhibitor |
| CHEBI has role | CHEBI:22587 | antiviral agent |
| CHEBI has role | CHEBI:35221 | antimetabolite |
| CHEBI has role | CHEBI:35610 | antineoplastic agent |
| CHEBI has role | CHEBI:35705 | immunosuppressive agent |
| CHEBI has role | CHEBI:38068 | antimalarial |
| CHEBI has role | CHEBI:50249 | anticoagulant |
| CHEBI has role | CHEBI:67079 | anti-inflammatory agent |
| CHEBI has role | CHEBI:75835 | anti-anaemic agent |
| CHEBI has role | CHEBI:233423 | antifibrotic agent |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 1.84 | acidic |
| pKa2 | 11.57 | acidic |
| pKa3 | 13.08 | acidic |
| pKa4 | 4.04 | Basic |
None
None
None
| ID | Source |
|---|---|
| 65093-40-5 | SECONDARY_CAS_RN |
| 3041 | RXNORM |
| C0089089 | UMLSCUI |
| AR3 | PDB_CHEM_ID |
| C061162 | MESH_SUPPLEMENTAL_RECORD_UI |
| 3I7U8R8NWC | UNII |
| 23671562 | PUBCHEM_CID |
| 372 | MMSL |
| 4526 | MMSL |
| d00201 | MMSL |
| 002649 | NDDF |
| 387511003 | SNOMEDCT_US |
| 89265009 | SNOMEDCT_US |
| C0010711 | UMLSCUI |
| CHEBI:135838 | CHEBI |
| DB00987 | DRUGBANK_ID |
| 6253 | PUBCHEM_CID |
| 1709 | INN_ID |
| 4018080 | VANDF |
| D003561 | MESH_DESCRIPTOR_UI |
| CHEBI:28680 | CHEBI |
None